News Image

IceCure's ProSense® Featured at Japanese Breast Cancer Society Conference: Updated Positive Clinical Data Shows 99% Recurrence Free Rate with Cryoablation

Provided By PR Newswire

Last update: Jul 25, 2025

Breast surgeon, Professor Eisuke Fukuma, a highly regarded cryoablation expert & ProSense® user at Kameda Medical Center, presented updated breast cancer cryoablation data from an independent study of over 600 women from 2006 to 2023

Read more at prnewswire.com

ICECURE MEDICAL LTD

NASDAQ:ICCM (9/25/2025, 8:00:02 PM)

After market: 1.0109 -0.02 (-1.85%)

1.03

-0.02 (-1.9%)



Find more stocks in the Stock Screener

Follow ChartMill for more